Luyan Pharma Co.,Ltd. (SHE:002788)
8.37
+0.02 (0.24%)
May 30, 2025, 2:45 PM CST
Luyan Pharma Revenue
Luyan Pharma had revenue of 5.17B CNY in the quarter ending March 31, 2025, with 0.74% growth. This brings the company's revenue in the last twelve months to 20.51B, up 1.83% year-over-year. In the year 2024, Luyan Pharma had annual revenue of 20.47B with 3.15% growth.
Revenue (ttm)
20.51B
Revenue Growth
+1.83%
P/S Ratio
0.16
Revenue / Employee
3.66M
Employees
5,602
Market Cap
3.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20.47B | 625.23M | 3.15% |
Dec 31, 2023 | 19.85B | 383.03M | 1.97% |
Jan 1, 2023 | 19.46B | 1.92B | 10.93% |
Dec 31, 2021 | 17.55B | 2.01B | 12.94% |
Dec 31, 2020 | 15.54B | 526.42M | 3.51% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |